IGF-1 has been investigated in clinical trials for the treatment of Duchenne muscular dystrophy (NCT01207908) and myotonic dystrophy type 1 (NCT00577577 and NCT00233519). The gene discussed is IGF1; the disease is myotonic dystrophy type 1.